Elevated fibrinogen to platelet is associated with increased all-cause mortality among patients undergoing primary percutaneous coronary intervention

J C Zhang; Y Y Zheng; J N Tang; B Qin; X M Yang; Q Q Guo; J C Guo; M D Cheng; Z L Zhang; F H Song; Z Y Liu; K Wang; L Z Jiang; L Fan; X T Yue; Y Bai; X Y Dai; R J Zheng; S S Yin; J Y Zhang

doi:10.23812/20-140-L

Elevated fibrinogen to platelet is associated with increased all-cause mortality among patients undergoing primary percutaneous coronary intervention

J Biol Regul Homeost Agents. 2020 Jul-Aug;34(4):1401-1405. doi: 10.23812/20-140-L.

Authors

J C Zhang^#^{1

2}, Y Y Zheng^#^{1

2}, J N Tang^{1

2}, B Qin³, X M Yang⁴, Q Q Guo^{1

2}, J C Guo^{1

2}, M D Cheng^{1

2}, Z L Zhang^{1

2}, F H Song^{1

2}, Z Y Liu^{1

2}, K Wang^{1

2}, L Z Jiang^{1

2}, L Fan^{1

2}, X T Yue^{1

2}, Y Bai^{1

2}, X Y Dai^{1

2}, R J Zheng^{1

2}, S S Yin⁵, J Y Zhang^{1

2}

Affiliations

¹ Department of Cardiology, First Affiliated Hospital of Zhengzhou University, China.
² Key Laboratory of Cardiac Injury and Repair of Henan Province, China.
³ Translational Medical Center, First Affiliated Hospital of Zhengzhou University, China.
⁴ Department of Cardiology, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
⁵ Institute of Medicine, University of Zhengzhou, Henan Province, China.

^# Contributed equally.

PMID: 32933232
DOI: 10.23812/20-140-L

No abstract available

Keywords: cardiovascular diseases; fibrinogen-to-platelet ratio; mortality; percutaneous coronary intervention.

Publication types

Letter

MeSH terms

Blood Platelets
Fibrinogen / analysis
Humans
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors / therapeutic use
Risk Factors
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Fibrinogen